United Kingdom Special Situations

FIH Group (FIH.L), an AIM-listed specialist services group operating in the Falkland Islands and the UK, declared a 40p special interim dividend per share following the £11.8 million net sale-leaseback of Momart Leyton and the £10.7 million net sale of Portsmouth Harbour Ferry Company. The dividend is payable July 14, 2026, to holders of record June 5, with an ex-date of June 4. Combined with a 70p special dividend paid in October 2025, total returns from the disposal program reach 110p per share, or approximately £13.8 million. Shareholders may reinvest distributions through a reinvestment plan with an election deadline of June 23. The 40p special dividend represents a 14.5% yield on the pre-announcement price of 225p, with the total 110p return signaling a management team returning approximately half the current share price directly to shareholders.

BlackRock Latin American Investment Trust plc (BRLA.L) announced that its self-tender offer for up to 24.99% of issued share capital was oversubscribed, with 29.6% of shares tendered. Basic Entitlement tenders will be satisfied in full, while Individual Excess Tenders have been scaled back to a proration rate of 76.8%. The tender price is set at 98% of the May 30, 2026 unaudited NAV per share, adjusted for portfolio realization costs, with Cavendish Capital Markets Ltd advising on the 7,359,215-share transaction. Final results and pricing are scheduled for June 2, 2026, with payments to be dispatched beginning June 3, 2026. The 76.8% proration rate provides a clean fill for arbitrageurs as the offer closes the exit window for 7.36M shares at a 2% discount to NAV, potentially tightening the discount for continuing holders as the remaining float shrinks.

BlackRock Smaller Companies Trust (BRSC.L) issued a valuation update for the tender pool established in connection with its combination with BlackRock Throgmorton Trust plc. The pool supports 11,147,581 ordinary shares held in escrow following the March 2026 tender offer. As of 28 May 2026, the pool is valued at £162.6M, consisting of £159.5M in cash and £3.1M in equities, resulting in a tender pool NAV per share of 1,458.63p. This update confirms the pool is 98 percent cash, implying limited market risk to the final repurchase price and setting a near-final floor for the capital return.

CVS Group (CVSG.L) launched a £50 million open-market share buyback programme, with Peel Hunt LLP and Joh. Berenberg, Gossler & Co. KG appointed to execute purchases for cancellation. The group concurrently refinanced £350 million in debt facilities with a syndicate of eight banks, extending the maturity to May 2030 and reducing the drawn margin by 20 bps. Irrevocable, non-discretionary arrangements have been established to allow share purchases to continue through closed periods. The board noted that macro and political uncertainty has impacted the company's share rating despite growth drivers following CMA clearance and FTSE 250 inclusion. This £50 million buyback signals board conviction that the post-CMA and post-refinancing valuation is dislocated, with the irrevocable mandate indicating the program will be used immediately rather than as a shelf announcement.

Johnson Matthey PLC (JMAT.L) is proceeding with the £1,325M enterprise value sale of its Catalyst Technologies business, which is on track to complete by the end of August 2026. The group intends to return £1 billion of net sale proceeds to shareholders, comprising an £800M special dividend with an associated share consolidation and a £200M on-market buyback. Concurrently, the company agreed to acquire CORMETECH Inc. for a $360M enterprise value, or 10.3x expected 2026 EBITDA pre-synergies, to expand its stationary emissions control business. A final ordinary dividend of 55.0p has been proposed with an ex-dividend date of 4th June 2026 and payment on 4th August 2026. The £800M special dividend and consolidation represents a material return of capital contingent on the single catalyst of the Catalyst Technologies sale closing by late August 2026, while the CORMETECH acquisition recycles proceeds into a growth adjacency tied to US data centre buildouts.

Schroder UK Mid Cap Fund (SCP.L) proposed a tender offer for up to 16,661,822 shares, representing 49.87% of issued capital, at NAV less costs. The proposal follows an agreement with 19.5% holder Saba Capital Management, which has committed to support the resolution, tender its full stake, and enter a three-year standstill agreement. The offer is conditional on a 75% approval threshold at a June 24, 2026 general meeting and the Maximum Tender Condition not being exceeded. Investec is advising on the transaction, with completion expected by August 1, 2026. Directors will not participate in the tender, and three directors intend to purchase an additional £120,000 in shares. Post-completion, the trust will target a mid-single digit discount through a new management policy.

Maven Renovar VCT (MRVM.L) shareholders today approved a self-tender offer for up to 12% of issued share capital with 95.29% of votes in favor. The offer provides a liquidity exit for the Venture Capital Trust, a structure that often trades at a discount to net asset value. The tender deadline is set for 1:00 p.m. on May 21, 2026, with results and pricing expected on May 26, 2026. Shareholders anticipate payment of tender proceeds by June 3, 2026. Total voting rights consist of 140,227,975 shares with none held in treasury.

3i Group (III.L) announced a share buyback programme of up to £750 million, commencing 14 May 2026. Barclays Bank PLC will execute the programme as a riskless principal through 31 December 2026. Purchased shares will be cancelled to reduce share capital, and repurchases will be announced within seven market sessions. The programme represents a significant capital return for the FTSE 100-listed private equity and venture capital firm and serves as a catalyst for EPS accretion through year-end.

Ecofin U.S. Renewables Infrastructure Trust (RNEP.L) resolved to return approximately $10 million to shareholders via a B Share bonus issue following recent asset disposals. The trust will issue B Shares pro-rata at a ratio of 1 for every 13.8078496 Ordinary Shares, followed by immediate redemption at $1 per B Share. Proceeds are equivalent to approximately 5.32 pence per Ordinary Share, to be paid in Sterling. The ex-date is 13 May 2026, with a record date of 14 May 2026 and redemption scheduled for 15 May 2026. This capital return mechanism provides a tax-efficient distribution reflecting the ongoing realization of the company's portfolio of U.S. renewable energy infrastructure assets.

Impax Environmental Markets (IEM.L) set the final price for its self-tender repurchase at 494.761953 pence per share, based on a tender pool final asset value of £738.4 million. The company accepted all 148,202,139 validly tendered shares for repurchase and cancellation, with no scaling back required as the tender was fully covered by distributable reserves. Winterflood Securities Limited will purchase the shares as principal on or around 19 May 2026. Shareholder payments are expected via CREST or cheque on 22 May 2026. These finalized terms provide certainty on pricing and liquidity for the capital return, eliminating valuation uncertainty and confirming full acceptance.

Keystone Law Group (KEYS.L) launched an on-market share buyback programme for up to £1.5 million on May 15, 2026, with purchases commencing immediately. Panmure Liberum Limited was appointed to execute the repurchases under an irrevocable instruction and within pre-set parameters. All repurchased shares will either be held in treasury to fulfill Long Term Incentive Plan commitments or cancelled. The program is funded through existing cash resources and intended to provide a return of capital to shareholders, though the £1.5 million size is modest for the company's scale. The launch signals confidence in cash generation from the firm's platform model involving nearly 500 self-employed lawyers. The next catalyst is expected on June 18, 2026.

Pantheon International PLC (PIN.L) announced that the majority of proceeds from a portfolio asset sale will be used to fund share buybacks as part of a targeted capital allocation strategy prioritizing shareholder returns. The private equity fund-of-funds expects the program to provide price support and signal undervaluation by potentially tightening the discount to net asset value. This asset sale represents a concrete capital return catalyst with significant execution expected in the near term.

Unite Group (UTG.L) completed the sale of St Pancras Way to USAF for £186M, with Unite’s share totaling £126M, at a 1% discount to December 2025 book value. Coinciding with the disposal, the board approved a £65M extension to its share buyback programme, bringing the aggregate authorization to £165M. The company has already executed £98M of an initial £100M tranche, repurchasing 19.3M shares at an average price of 504p. Funded by the asset disposal proceeds, the extended buyback is scheduled to run until the earlier of completion or October 31, 2026. Deutsche Bank and J.P. Morgan Securities are acting as executing brokers for the programme.

Deltic Energy (DELT.L) has published the scheme document for its recommended all-cash acquisition by NEO NEXT+ via a court-sanctioned scheme of arrangement. The publication sets the shareholder vote for 24 June 2026, with proxy deadlines established for 22 June 2026. Deltic directors unanimously recommend the transaction and have provided irrevocable undertakings representing 0.26% of the issued share capital. To support the process, NEO NEXT+ provided a £2.9M bridge loan facility, drawn on 14 May 2026, to repay an existing facility held by RockRose. Approval requires a majority in number and 75% by value at the Court Meeting; since irrevocable undertakings cover only 0.26% of the capital, turnout and proxy solicitation will determine whether the scheme clears statutory thresholds.

The HSR waiting period for the $6.3B acquisition of Centessa Pharmaceuticals (CNTA) by Eli Lilly and Company has expired, satisfying a U.S. antitrust closing condition. Structured as a UK scheme of arrangement, the transaction requires shareholder and High Court approval and includes contingent value rights tied to milestone achievements. Regulatory clearance de-risks the transaction and narrows the path to close, potentially tightening the spread for arbitrageurs positioning ahead of the scheme vote.

Intertek (ITRK.L) stated its board is minded to recommend a fourth and final cash takeover offer from EQT AB at £60.00 per share, valuing the company at approximately £9.2B. The proposal follows three prior bid rejections and pressure from shareholders, including Matt Peltz and Harris Associates LP, to engage with EQT. Intertek has paused its previously announced strategic review to prioritize these negotiations. Morgan Stanley is advising EQT, while Goldman Sachs and JPMorgan Chase are advising Intertek.

Evoke (DI) (EVOK.L) extended the firm offer deadline for Bally's Intralot S.A. to 5:00 p.m. London time on 8 June 2026 as discussions continue regarding a possible all-share offer with a partial cash alternative at 50 pence per share. The extension was granted at the request of Bally's Intralot S.A., which reserves the right to vary terms including price, consideration mix, and transaction structure. Evoke (DI), a Gibraltar-registered online gambling and betting operator formerly known as 888 Holdings, is being advised by Morgan Stanley and Rothschild & Co. A firm offer at 50 pence per share could represent a control premium for shareholders, with the extended deadline serving as a catalyst for deal resolution.

Westmount Energy Ltd. (WTE.L) provided an update on the acquisition of JHI by its investee Eco via a court-approved plan of arrangement. JHI shareholders voted 100% in favor of the transaction on May 12, 2026, and the Ontario Superior Court issued a final order approving the arrangement on May 15, 2026. Remaining closing conditions include TSX-V and AIM approvals, a Falkland Islands government license extension, and JHI reaching a US$1M cash balance. Upon completion. Westmount will hold 9.53M Eco shares, including 4M locked-up shares, up from its existing 1.5M Eco shares. The acquisition directly impacts Westmount's net asset value as its value derives substantially from its holding in Eco. Cavendish Capital Markets Limited is acting as advisor.

Ajax Resources (AJAX.L) and vendor Asara Resources Ltd extended the exclusivity period for the acquisition of the Paguanta Project until 14 August 2026. The companies are currently finalizing terms for a sale and purchase agreement for the near-production silver project in Chile. Paguanta holds a JORC-compliant resource of 6.8 Moz Ag, 265 Mlb Zn, and 74 Mlb Pb, with historical expenditure of approximately US$31.5 million. The former silver mine includes 14 granted exploration licenses covering 7,800 hectares. Completion is expected no later than the 14 August 2026 exclusivity deadline. Allenby Capital Limited is acting as advisor to Ajax Resources.

Augmentum Fintech (AUGM.L) received sanction from the High Court of Justice in England and Wales for the scheme of arrangement regarding its recommended cash acquisition by Frontier Bidco Limited, an entity controlled by Verdane. All regulatory conditions have been satisfied, including FCA approval of control over AFML and Retail Book. The scheme record time is set for 6:00 p.m. on 12 May 2026, and the transaction is expected to become effective on 13 May 2026 upon delivery of the court order to the Registrar of Companies. Cavendish Capital Markets Limited is acting as advisor to Augmentum, while Houlihan Lokey UK Limited is advising Frontier Bidco and Verdane.

Vossloh AG reached a definitive agreement to acquire 100% of Cordel Group PLC (CRDL.L) via a court-sanctioned scheme of arrangement. The cash offer of 12.4 pence per share values Cordel at approximately £29 million on a fully diluted basis, representing a 107% premium to the closing price of 6.0 pence. Cordel Directors, advised by Strand Hanson, have unanimously recommended the transaction, which will be executed through Vossloh’s wholly-owned subsidiary Vossloh Digital Solutions GmbH. The bidder has secured irrevocable undertakings representing approximately 48.9% of Cordel’s issued share capital, including a 17.9% stake held by Cordel Directors. The announcement on 13 May 2026 triggers the formal 28-day timetable for the publication of the Scheme Document.

Doctor Care Anywhere (DOC.AX) signed a binding asset purchase agreement on May 8, 2026, to acquire the GLP-1 and medicated weight-loss business of Outcome Diagnostics and MedicSpot for £850,000 (~A$1.7 million). The purchase price is funded from existing cash with no earn-out or deferred consideration, representing a 0.16x EV/Sales multiple. The acquired business generated £5.3 million (~A$11 million) in trailing 12-month revenue to March 2026 and is broadly EBITDA breakeven. The transaction provides immediate entry into the UK GLP-1 weight-loss market and adds direct-to-consumer capabilities to the telehealth platform. The deal is not subject to material conditions precedent and does not require shareholder approval. Doctor Care Anywhere maintains an existing £14 million cash balance.

Intertek (ITRK.L) has granted EQT due diligence access and indicated it is prepared to recommend a cash proposal of £60.00 per share if it proceeds to a firm offer. The proposal values Intertek’s equity at approximately £9.4 billion, reflecting a potential total payout of up to £61.077 per share including a 107.7p dividend. This offer represents a premium of up to 62% over the April 9 closing price. The board’s engagement follows pressure from Lost Coast Collective, which holds a 1.2% stake, along with PrimeStone Capital and Palliser Capital, after three previous rejections. Intertek has paused its strategic review pending the outcome of EQT’s due diligence. The UK Takeover Panel has established a June 11 deadline for EQT to announce a firm intention to make an offer.

Logistics Development Group plc (LDG) announced that its 39.5%-owned portfolio company, WS Holdco, acquired Walkers Transport Holdings Limited and Madex Logistics. Walkers Transport provides UK and Ireland pallet distribution with international freight forwarding, and Madex Logistics operates a London hub with a network into mainland Europe. The combined group is expected to generate annual revenues exceeding £400 million. No additional investment from LDG was required for the acquisitions. Strand Hanson Limited and Singer Capital Markets are acting as advisors.

AMG Lithium B.V. announced a recommended cash-and-share offer for Zinnwald Lithium plc (ZNWD.L) on 14 May 2026, valuing the company at approximately £57M (around $56M). Consideration is split equally between cash and newly issued AMG shares rather than pure cash. Allenby Capital is advising on the firm offer, which was disclosed by the UK Takeover Panel on 15 May 2026 with a definitive agreement reached. Zinnwald Lithium owns the Zinnwald Lithium Project in Germany, the second-largest hard rock lithium project in the European Union. The proposed acquisition of the strategic pre-production asset occurs as European critical mineral security is a policy priority, creating potential for competing bids following the company's recent fundraising at a low valuation.

Physiomics (PYC.L) has completed a wholesale board replacement following a shareholder vote where over 75% of investors removed former chair Dr. Jim Millen. Activist Mike Whitlow was appointed executive director, while CEO Dr. Peter Sargent was retained to provide management continuity. Following the board overhaul, the company announced multiple contract wins totaling over £345,000 from international and UK-based biotech and oncology organizations. These follow-on contracts signal the new board's operational focus and confirm the leadership change is translating into commercial momentum. This commercial traction so soon after the coup de-risks the activist thesis that board change would unlock value and serves as a material revenue signal for the AIM-listed micro-cap firm.

Corvex Management disclosed a 7% stake in Whitbread plc (WTB.L) and demanded the board initiate a comprehensive sale process while threatening to nominate a slate of directors if the board fails to comply. Corvex argues that Whitbread's share price of approximately £23, a 13-year low, suggests the market effectively ascribes zero value to the company’s leasehold business, German assets, and development properties. The activist is calling for an immediate suspension of non-essential capex and sale-leaseback transactions in favor of a share buyback program. This public escalation follows the board's rejection of a private capital-strategy review request in December and its recent announcement of a 14,000-room expansion plan in the UK and Germany. The move marks Whitbread’s first formal board-control contest and seeks to surface a freehold property value gap where the stock trades at less than 8x pre-tax profit against the value of UK freehold assets alone.

Alternative Income REIT (AIRE.L) issued a public rebuttal to activist demands and a possible cash offer from Glenstone REIT plc, which controls a 26.4% stake. Glenstone’s demands include a managed wind-down, the appointment of a Glenstone executive to the board, and a transfer of the listing to. The International Stock Exchange. Independent directors rejected these demands and denied due diligence access, noting that a prior 66.5p per share proposal represented a 20.8% discount to NAV. AIRE’s board currently supports a separate possible offer from AEW UK REIT at a 3% discount to NAV. Glenstone and director Adam Smith control a combined 26.4% interest, with Shore Capital acting as advisor. A next catalyst date for the situation is June 12, 2026.

Bernstein, the founder of Crystal Amber, has issued a letter to the chairman of Porvair (PRV.L) urging the board to explore strategic alternatives, including a potential sale. Bernstein, who holds a personal stake in the specialist filtration and laboratory technology group, cited a lackluster year for the shares and claimed the company is trading substantially below its strategic value. The public demand follows a recent shareholder vote where 24% of votes were cast against the chairman's re-election. Porvair shares rose 3.5% to 774p on the news.

Saba Capital Management is calling for the replacement of all non-executive directors at Workspace Group (WKP.L), an escalation from prior demands for board representation. Workspace Group is a London-listed real estate investment trust focused on flexible office space for SMEs and is currently executing a £200 million disposal programme. Recent activity under this programme includes the sale of Peer House in Holborn. The campaign for full board replacement creates a potential catalyst for governance overhaul, strategic change, or asset sales.

Corvex Management, holding a 7% stake in Whitbread (WTB.L), issued a public letter demanding the owner of the Premier Inn hotel chain put itself up for sale. The activist argues that the company's five-year plan announced in April 2026 is insufficient, with the stock trading at a 13-year low of approximately £23/share and below 8x pre-tax profit. Corvex signaled it will nominate a new slate of directors if the board does not publicly commit to a formal sale process. Whitbread's board previously declined to include Corvex in its strategic process in December 2025. The company responded that its current plan followed a rigorous review and is designed to deliver £2bn of free cash flow by FY31. The stake and threat of a proxy contest could catalyze a strategic alternatives review, break-up, or take-private transaction.

Intertek Group plc (ITRK.L), a global total quality assurance provider, received an unsolicited third and final cash offer from EQT at a 38% premium, following prior bids of £51.50 and £54. The board is minded to recommend the offer should a firm bid be made and confirmed that work on its strategic review is paused to allow for due diligence. Activist investors Lost Coast Collective and Primestone Capital, holding 1.2% and 0.5% stakes respectively, issued open letters urging the board to engage with EQT. Lost Coast Collective argues the all-cash bid represents superior risk-adjusted value compared to the company’s standalone break-up plan, citing a 17% spread. The UK Takeover Panel extended the deadline for EQT to make a firm offer to 11 June 2026.

Oasis Management Company Ltd. disclosed a 15.2138% total economic interest in Capita (CPI.L), a UK-based professional services company. As of May 7, 2026, the position includes 6.44% in direct voting rights and 8.78% through cash-settled total return swaps. Seth Hillel Fischer, the ultimate controlling person of Oasis, restructured the exposure from a prior notification of 0% direct shares and 15.00% through derivatives. This conversion of derivative exposure into direct voting shares signals a potential escalation toward a public campaign.

Converium Capital Inc, holding a 2% stake in CVS Group PLC (CVSG.L), has demanded that the UK veterinary services provider launch an immediate GBP100 million share buyback representing 12.5% of its market capitalization. The activist has threatened to rally shareholders to nominate new directors to the board if the buyback demand is ignored. Converium criticized board inaction following the conclusion of a UK CMA investigation into veterinary pricing practices in March 2026 and characterized the buyback as the highest-return use of capital. CVS shares have declined 20% since October 2025. Converium historically targeted Foxtons Group in 2022 to demand a formal sale process.

Cevian Capital II GP Limited increased its voting rights in Smith & Nephew (SNN) to 11.013663% from 10.094356%, according to a May 14 TR-1 filing. The position represents 94.1 million voting rights and crossed a disclosure threshold on May 11, intensifying pressure on the British medical technology company to deliver a rebound in its U.S. knee implant business. Smith & Nephew reported Q1 2026 revenue of $1.50 billion with 3.1% underlying growth, missing consensus of 3.2%, while facing $60 million in tariff costs and a $20 million to $40 million impact from a U.S. reimbursement change. The increased stake signals Cevian’s conviction in its activist thesis and raises the probability of escalating demands targeting the company’s orthopaedics turnaround strategy.

Saba Capital doubled its stake in Syncona Limited (SYNC.L) to 10% of shares outstanding. Syncona is a UK-listed investment trust focused on building and holding a portfolio of biotechnology companies. Shares in the trust have declined 59.2% over the past five years. Syncona recently reversed a planned wind-down in favor of a £250m cash return to shareholders. The increased stake by Saba Capital signals an escalating campaign for further corporate action or board changes.

Molten Ventures (GROW.L) announced a further partial realization of its Revolut holding for circa £63 million. Total realizations from the stake now stand at circa £120 million, representing an approximate 20x multiple on invested capital. The firm's remaining Revolut holding is valued at circa £110 million as of March 31, 2026. Total realizations across the Molten Ventures portfolio have exceeded £300 million since April 2024. Realizing the high-profile fintech stake demonstrates potential for NAV uplift and capital returns.

Anglo American (AAL.L) entered into a definitive agreement to sell its steelmaking coal business for up to US$3.875 billion in cash. The transaction represents a major step in the company's portfolio simplification toward copper, premium iron ore, and crop nutrients. This divestiture follows ongoing structural changes, including the separation of De Beers and the nickel business.

Anglo American (AAL.L) has entered into a definitive agreement to divest its nickel business to MMG Singapore Resources Pte. Ltd. The transaction, which includes the Barro Alto and Codemin assets in Brazil, is currently awaiting antitrust approval from the European Commission. Anglo American's Q1 2026 nickel production fell 34.8% year-on-year to 9,100 tonnes due to maintenance at these plants. This divestiture is part of a broader portfolio restructuring following the previous separation of the group's South African refined nickel business into Valterra Platinum.

ASOS (ASC.L) entered into a definitive agreement on May 9, 2026, to sell its leasehold interest in the Lichfield fulfilment centre and associated automation equipment to Marks and Spencer Plc for £67.5M cash. Advised by Teneo, the divestiture is expected to close in H2 2026 and generate net proceeds of at least £66M. The sale follows ASOS’s November 2025 refinancing and April 2026 bond repayment, with proceeds earmarked to improve the net debt position and maintain financial flexibility for strategy execution. The transaction is projected to yield annual cash cost savings of approximately £6M and an anticipated one-off profit before tax of £85M, crystallizing value on an asset carried at £nil as of March 1, 2026. Completion remains subject to customary consents.

Norcros (NXR.L) has initiated a formal strategic review to explore the sale of its remaining South African operations, Norcros SA. The segment comprises TAL, Tile Africa, and House of Plumbing, and it generated £99.4 million in revenue and £6.7 million in underlying operating profit during FY25. Management expects the sale process to take approximately 12 months, subject to South African competition review. A disposal of this material segment would complete a strategic repositioning of Norcros as a capital-light bathroom products group focused on the UK and Europe.

Schroder UK Mid Cap Fund plc (SCP.L) will launch a 100% tender offer at NAV per share to facilitate a full exit by Saba Capital. Saba has agreed to tender its entire holding and signed a three-year standstill agreement. The deal requires 75% shareholder approval at a general meeting scheduled for 24 June 2026. Board directors will vote in favor but will not tender, with three directors committing to purchase £120k in additional shares. Following the exit, SCP will adopt a discount management policy targeting a mid-single-digit discount to NAV. The settlement resolves a long-running activist overhang and allows for a reset of the fund's capital base.

Alternative Income REIT plc (AIRE.L) has received a possible all-cash offer from 24.0% shareholder Glenstone REIT PLC following the 21 April 2026 withdrawal of potential buyer AEW UK REIT. No offer price has been disclosed, and any bid remains subject to confirmatory due diligence, lender consents, and Glenstone board approval. Glenstone, advised by J Goodwin & Co, must announce a firm intention to bid or withdraw by 5:00 p.m. London time on 12 June 2026. If a transaction proceeds, Glenstone intends to transfer the listing to. The International Stock Exchange to maintain REIT status and reduce costs. Alternative Income REIT plc is a real estate investment trust listed on the London Stock Exchange that holds a portfolio of commercial properties and has not raised equity since its 2017 IPO.

Tate & Lyle plc (TATE.L) announced on 14 May 2026 that it received a possible all-cash offer from Ingredion Incorporated at 595 pence per share. This proposal for the FTSE 250 food and beverage ingredients supplier triggered a surge of Form 8.3 stakeholder and Form 8.5 exempt principal trader filings on 15 May 2026. Under the UK Takeover Panel’s Rule 2.6 deadline, Ingredion must announce a firm intention to offer or walk away. The potential bid for the specialty ingredients company creates a merger-arbitrage spread to track as regulatory deadlines force a binary catalyst.

Herald Investment Trust net assets are approximately £1.4B. The tender is for up to 66% of outstanding shares at close to NAV, with cash or in-specie options.

Advanced Medical Solutions (AMS.L) confirmed receipt of an unsolicited, non-binding cash proposal from H.B. Fuller Company following the May 18 termination of buyout talks with TA Associates. The proposal reportedly values the UK-based tissue-healing and wound-care developer at over £600 million. H.B. Fuller shareholder Ancora publicly opposed the acquisition on May 26 and urged the bidder to withdraw its bid. The situation is currently in a pre-offer period with no UK Takeover Code timetable yet established. The emergence of a second suitor creates a contested take-private target, though Ancora’s opposition introduces a deal-break risk from the acquirer side while the lack of a PUSU deadline leaves either party able to walk before an arb spread can be established.

Bidco will implement the compulsory acquisition of remaining shares in Essensys (ESYS.L) following a recommended cash offer of 17 pence per share. The transaction follows the offer being declared unconditional on 8 May 2026 after receiving 97.01% acceptances. Essensys applied for AIM delisting on 11 May 2026, and Bidco is proceeding under sections 979-980 of the Companies Act for non-assenting holders ahead of a 26 June 2026 expiry date. The offer remains open for acceptances until 1:00 p.m. on 28 May 2026. Kroll Securities Limited is acting as advisor to Bidco, and Canaccord Genuity Limited is advising Essensys.

Idox plc (IDOX.L) has entered the final squeeze-out phase of its take-private by Bidco after reaching 90.2% valid acceptances as of 5pm on 11 May 2026. Crossing the 90% threshold under Chapter 3 of Part 28 of the Companies Act 2006 enables the immediate issuance of formal compulsory acquisition notices under sections 979-980. A six-week statutory period will precede compulsory vesting, though the offer remains open for acceptance until 1:00pm on 14 May 2026. Admission of shares to AIM is expected to be cancelled effective 7:00am on 29 May 2026, with Idox to be re-registered as a private limited company thereafter. Rothschild & Co is lead financial adviser to Idox, with Peel Hunt serving as joint financial adviser and Canaccord Genuity acting for Bidco and Long Path.

Aptitude Software Group plc (APTD.L) has initiated a board-led strategic review including a formal sale process to maximize shareholder value. The review is supported by several major shareholders and aims to secure resources to accelerate the Fynapse platform within the Finance ERP market. Following the initial launch on April 8, the company confirmed the formal sale process is actively underway with the board moving into active solicitation of bids. No definitive timeline has been disclosed, and the board indicated further updates will be provided in due course. The formal launch positions the UK-listed micro-cap for takeout optionality with major shareholder backing, though the absence of a named advisor or timeline indicates the process is early-stage.

Kazera Global (KZG.L) is evaluating strategic pathways for its interest in African Tantalum (Pty) Ltd (Aftan), a tantalum and lithium project in southern Namibia, amid rising interest from third parties and tantalum prices reaching multi-decade highs. The company retains legal title to Aftan shares as security following a binding arbitration victory against Hebei Xinjian Construction. Recent technical analysis identifies potential for dry beneficiation to improve project economics and district-scale exploration upside across 13 known mineralised pegmatites, only three of which have modern resource estimates. Strand Hanson Limited is advising on the review.

Tooru PLC (TOO.L) formally terminated its proposed acquisition of Netherlands-based Mylky B.V. this morning, citing market conditions, geopolitical risk, and the significant new debt required by the transaction. Diligence revealed unacceptable exposure to European legislation risk for the enlarged group, while equity financing was deemed too dilutive at the company's current valuation. Tooru, which is advised by Beaumont Cornish, will refocus on near-term organic growth and UK acquisitions as the vendor fields alternative offers. This termination removes a transformative European acquisition overhang, and while the board's language suggests the vendor is advancing alternative conversations, the stock remains illiquid with reduced selling pressure from deal-arb unwinds and no immediate new catalyst.

TA Associates announced on 15 May 2026 that it does not intend to make an offer for Advanced Medical Solutions Group (AMS.L), formally terminating a possible offer first disclosed on 18 April 2026. Under Rule 2.8 of the Takeover Code, TA Associates is now restricted from making an offer for the medical device manufacturer for six months. These restrictions may be set aside if a third-party bidder emerges, the board consents, or the company proposes a Rule 9 waiver or reverse takeover. The withdrawal concludes a potential take-private for the producer of wound care dressings and surgical sealants. This termination removes a near-term M&A catalyst while leaving a "fallen bid" setup that could attract other bidders or shift focus to standalone value.

Maintel Holdings (MAI.L) closed its retail offer, raising £0.5 million at 80p per share as part of a conditional £5.5 million aggregate fundraising. The capital raise is contingent on a concurrent refinancing, shareholder approval at a June 1, 2026, General Meeting, and AIM admission. Maintel is currently in ongoing negotiations with lenders to meet the June 30, 2026, long-stop date required for the fundraising to complete. Proceeds are intended to strengthen the balance sheet and support a transformation programme at the managed communications provider. The conditional equity raise is explicitly tied to the concurrent refinancing, signaling balance-sheet distress and creating a near-term binary catalyst as of the June 30 long-stop date.

Maintel Holdings (MAI.L) launched a £6 million fundraising package comprising a placing, convertible loan notes, and a retail offer of up to 1,250,000 ordinary shares at 80 pence. The issue price represents a 33.3% discount to the May 12, 2026, closing price of 120 pence. The fundraising is conditional upon Maintel entering into a new facility agreement or refinancing existing debt facilities with third-party lenders. Gross proceeds will be used to strengthen the balance sheet, fund a transformation programme, and provide working capital for new projects. A General Meeting is required to pass fundraising resolutions, and Cavendish Capital Markets Limited is acting as advisor and underwriter. Admission of the retail offer shares is expected on June 2, 2026.

Axiom Intelligence Acquisition Corp 1 (AXIN) filed a Sponsor Support Agreement dated May 25, 2026, in connection with its proposed business combination with Swiss quantum technology firm Terra Quantum AG. The sponsor, Axiom Intelligence Holdings 1, LLC, has committed to vote all SPAC founder shares and rights in favor of the transaction and waived all dissenters' rights. The deal is structured as a two-step merger involving the SPAC merging into a merger sub, followed by a Swiss HoldCo merging into the surviving public entity. Although a Business Combination Agreement was signed on May 25, 2026, the definitive agreement has not yet been filed with the SEC. This filing locks in the sponsor vote and signals progression toward a formal proxy statement, with a shareholder vote typically occurring 8–12 weeks after the definitive agreement is fully filed.

BlackRock Throgmorton Trust Plc (THRG.L), currently in Members' Voluntary Liquidation under a Scheme of Arrangement, reported that Cash Pool shareholders elected for equities valued at £170.2M, cash collateral of £11.5M, and accrued dividends of £2.1M. Cash Pool participants elected for equities valued at £15.7M, cash collateral of £170.1M, and accrued dividends of £0.6M. Joint Liquidators have delayed the initial distribution until substantially all remaining equities are realized, which is expected to occur within two weeks. The liquidators are optimizing the final distribution by waiting for full portfolio realization rather than making a partial payout now, and PMs should monitor the next announcement for the distribution amount and record date as cash realization of £170M+ in the Equity Pool suggests a material near-term payout.

Puretech Health Plc (PRTC) filed Amendment No. 1 to its American Depositary Shares (ADS) deposit agreement with Citibank, N.A. to reflect the company's prior delisting from NASDAQ and the termination of reporting obligations under the Exchange Act via Form 15F. The amendment updates ADR terms to reflect the cessation of filing duties under Sections 13(a) and 15(d). Following Form 15F effectiveness, the company will publish information on its website under Rule 12g3-2(b). The amendment is dated as of an unspecified date in 2026 and binds all existing and future ADS holders. This formalization of the going-dark process terminates SEC reporting access and Exchange Act protections for ADS holders.

Marex Group Plc (MRX), a diversified global financial services platform, obtained requisite consents from holders of its 6.404% Senior Notes due 2029 to amend the governing indenture, permitting a new Bermuda parent holding company to assume its obligations. The amendments facilitate a proposed redomiciliation from England and Wales to Bermuda, which can alter the company's regulatory, tax, and governance profiles. Consenting holders receive $1.00 per $1,000 principal, with settlement and execution of the supplemental indenture occurring on May 19, 2026. Goldman Sachs & Co. LLC is serving as advisor. The successful solicitation removes a key obstacle to the move and signals progress toward completion of the redomiciliation announced on March 26, 2026.